Table GPS-5. Last 12 months prevalence of drug use by age, gender and country, most recent national general population survey available since 2000 [see all tables in this series...]

Part (iii) Young adults male (aged 15–34)

Notes:

 (1) Cocaine, any form. 

 (2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy. 

 (3) For Spain: ecstasy and other synthetic drugs. 

 (4) The most recent General population surveys reported by the Czech Republic display a wide variation in results, the reason for which is being explored, but may be due to differing sampling methods. The data is provided for information, but given the lack of comparability between surveys should be treated with caution. 

 Sample sizes refer to the whole age group. Specific sample sizes by gender are not available at the moment but will be collected in the future. 

 This table aims to provide an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates, which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as a reference point for the 1993 survey.  

 In surveys with small sample sizes results should be interpreted with caution. 

 Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15–64, young adults: 15–34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.  

 For methods and definitions see General population surveys of drug use – methods and definitions. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

Sources:

 See Table GPS-0.  

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)